Marketing itself as “your new best friend in fashion”, Cosette says it sources authentic designer bags at a discounted price from European suppliers by taking advantage of parallel importing ...
Bridgewater-based Cosette issued a statement Dec. 11 saying it served a notice to the Australia-headquartered pharmaceutical company two days prior terminating the agreement. The deal was originally ...
(Reuters) -An Australian court on Wednesday stopped U.S. drugmaker Cosette from abandoning its A$672 million ($437.6 million) takeover of Mayne Pharma, which now awaits clearance from the Foreign ...
BRIDGEWATER, N.J., December 16, 2025--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated pharmaceutical company, announced today that the U.S. Food and Drug Administration ...
Cosette Pharmaceuticals Appoints Erika Tooman as Senior Vice President, General Counsel, Strengthening Leadership Team to Drive Accelerated Growth and Strategic Expansion -- Experienced life sciences ...
American pharmaceutical giant Cosette has terminated its $672 million takeover bid for Adelaide-headquartered drug company Mayne Pharma, but the target company says it will challenge the move in the ...
With a $430 million buyout of Australia’s Mayne Pharma locked down, Cosette Pharmaceuticals is looking to become a leading force in women’s healthcare. The New Jersey-based drugmaker agreed to ...
A bombshell report in The Age identified a customer who had put her handbag – a Saint Laurent Envelope Medium Chain Bag – through the official authentication process, only to be told it was not the ...
Bridgewater-based Cosette Pharmaceuticals announced Feb. 20 it entered into an agreement to acquire Mayne Pharma Group Ltd. in a $430 million deal. Mayne is an Australian-headquartered specialty ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results